Qsymia Approval Raises Safety Worries
Widespread Concerns Over Qsymia Diet Drug Safety. A new prescription obesity and diet drug has been approved for use in the U.S. and like many of its predecessors, there are widespread concerns over its safety. The Food and Drug Administration this week approved Qsymia as a drug treatment for obesity. While early … [Read more...] about Qsymia Approval Raises Safety Worries
Dim Future for Medtronic Infuse
Cancer and Other Side Effects of Medtronic Infuse. Medtronic Inc.'s sales of its Infuse (rhBMP-2) product have taken a hit in recent months, thanks to concerns that the bone growth protein may be associated with cancer and other serious side effects. Now one analyst is raising doubts as to whether Medtronic can salvage … [Read more...] about Dim Future for Medtronic Infuse
Multaq Losing Favor
Multaq Safety Concerns. Multaq is coming under increasing scrutiny in both the U.S. and Europe as concerns about its safety and effectiveness continue to mount. At the same time, many doctors appear to be backing away from Multaq because of safety concerns. Multaq is approved to treat temporary atrial fibrillation. In … [Read more...] about Multaq Losing Favor
